AWA Point
Increasing Burden of Proof for Trademark Applicants in China
By Ashley Zhao | Posted on March 19, 2025
Based on the recent official notices issued by the CNIPA (China National Intellectual Property Administration) about non-use cancellation cases, applicants are now required to submit more stringent evidence to prove that the target trademark has not been used, including: Basic information about the trademark registrant, including business scope, operational status, and trademark registration details. Evidence...
Companies with IP generate at least 23.8% more revenue according to latest EU report
By AWA | Posted on February 5, 2025
The report ‘The Intellectual Property Rights and Firm Performance in the European Union’ was published last month and analyses intellectual property records by matching firms with their registered patents, trademarks, and designs from multiple authorities, including the European Patent Office (EPO), European Union Intellectual Property Office (EUIPO), and various national and regional IP offices within...
Filed under: Insights
Tags: EPO, EUIPO, Intellectual Property, patents, SMEs, trademarks
European Commission reports show misuse of divisionals can in itself contravene EU law
By Mikkel Roed Trier | Posted on January 28, 2025
In November last year, I was interviewed about the European Commission’s €462.6 million fine against pharmaceutical giant Teva and what it could mean for European patent practices. In short, the European Commission fined Teva for artificially extending patent protection by pursuing divisionals and spreading misleading information about a competing product to hinder its market entry...
IP Enforcement Strategies: Combating Counterfeiting in Southeast Asia and China
By Angeline Lee | Posted on January 27, 2025
Counterfeiting remains among the most significant threats to intellectual property rights globally, particularly in Southeast Asia and China. These regions are at the heart of global manufacturing and trade but also experience high levels of IP violations. In recent years, efforts to curb counterfeiting in these areas have evolved, with countries intensifying their enforcement strategies...
How foreign applicants can take advantage of China’s updated patent regime
By Benny Liu | Posted on January 27, 2025
China implemented the fourth amendment to its Patent Law, which came into effect on 1 July 2021. The amended Implementing Regulations and Guidelines took effect on 20 January 2024. This fourth round of amendments introduced several positive elements for foreign applicants. Procedural Changes Restoring Priority In line with patent practices in the UK, European Union,...
Filed under: Insights
Tags: applicants, china, designs, examination, patents, priority, Procedure
CNIPA releases detailed guidelines on trademark licences
By Ai-Leen Lim | Posted on January 27, 2025
China’s Trademark Law stipulates that, when granting others the right to use registered trademarks, the licensor must record the licence with the China Trademark Office (CTMO). On 29 October 2024 the China National Intellectual Property Association (CNIPA) released the Guidelines on Registration Procedures for Trademark Licences, to help businesses understand the relevant legal provisions and...
Tags: china, CNIPA, Guidelines, licences, registration, trademarks
AI and Intellectual Property
By Hanna Hansson | Posted on December 17, 2024
In this webinar from December 2024, Henrik Aurell, European Patent Attorney, and Hanna Hansson, IP Lawyer, deliver a presentation on emerging IP challenges and legal issues surrounding AI-generated content.
Filed under: Webinars
Interview: Will patent filers have to change practices after European Commission’s €462.6 million fine against big pharma’s Teva?
By AWA | Posted on November 26, 2024
The European Commission recently fined pharmaceutical giant Teva €462.6 million for artificially extending patent protection by pursuing divisionals and spreading misleading information about a competing product to hinder its market entry and uptake. Margrethe Vestager, the Commission’s Executive Vice-President in charge of competition policy, commented that the decision “reaffirms the Commission’s commitment to competition enforcement...
Filed under: Insights, Interviews
Tags: antitrust, competition, divisionals, EU, patents, Teva
New rules for medical devices and in vitro diagnostic medical devices
By Isa Böttiger | Posted on October 2, 2024
In recent years, several new and amended requirements have been introduced for medical devices and in vitro diagnostic devices to be placed on the European market. On 9 July 2024, the EU introduced the latest amendments to the regulatory landscape in this field through Regulation (EU) 2024/1860. In 2017, the EU introduced two new regulations...
Danish Copyright Act – You may (still) lawfully use copyrighted works for parody purposes
By Mette Parlev | Posted on June 10, 2024
An amendment to the Danish Copyright Act will enter into force on July 1, 2024. The amendment codifies a long-used principle in Danish law that the use of copyrighted works in parodies and caricatures does not constitute an infringement of the work. This principle faltered when the Eastern High Court suddenly changed it in a...
Recent contributors
Partner, Attorney at Law, Business Area Manager
Associate, Attorney at Law, European Trademark and Design Attorney
Senior Associate, Patents
Partner, European Patent Attorney, Authorised Swedish Patent Attorney, UPC Representative
Partner, Attorney at Law, Group Vice President
Senior Associate, Attorney at Law